'Exceptionalism,' Preemption And A Test For FDA Authority
By Hannah Albarazi · November 11, 2025, 10:38 AM EST
The U.S. Food and Drug Administration's broad authority over drug approvals is being tested as state lawmakers impose new restrictions on mifepristone, the abortion drug that has seen surging use across...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login